Testosteronologist® Mailbag 56

This mailbag discussion focuses on questions about when to remain patient versus when to reassess during testosterone therapy. It explains that not every concern requires immediate action and that timing matters in interpretation. Patience is framed as an active clinical decision rather than inaction.
A central portion discusses how labs, symptom duration, and overall trajectory help determine when reassessment is appropriate. The episode emphasizes distinguishing transient fluctuations from meaningful patterns. Contextual interpretation is highlighted to guide decisions.
The closing segment reinforces testosterone therapy as longitudinal clinical care. Ongoing monitoring, proportional responses, and expectation alignment are emphasized. Hormone therapy is positioned as benefiting from measured reassessment rather than constant change.